New hope for Treatment-Resistant schizophrenia? phase 3 trial launches

NCT ID NCT07184619

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study tests an experimental drug called evenamide for people with schizophrenia that hasn't improved with standard antipsychotics. About 400 adults will receive either evenamide or a placebo added to their current medication for 12 weeks. The goal is to see if evenamide reduces symptoms like hallucinations and delusions better than placebo, and to check its safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Schizophrenia Schizophrenia, Treatment-Resistant treatment-refractory schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Ahana Hospitals LLP

    RECRUITING

    Madurai, Tamil Nadu, 625020, India

  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine

    SUSPENDED

    Baltimore, Maryland, 21224, United States

  • Gauhati Medical College and Hospital

    RECRUITING

    Guwahati, Assam, 781032, India

  • Grady Behavioral Health Center, -Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine

    SUSPENDED

    Atlanta, Georgia, 30322, United States

  • Help Hospital

    RECRUITING

    Vijayawada, Andhra Pradesh, 520002, India

  • Hospital Tuanku Fauziah

    RECRUITING

    Kangar, 01000, Malaysia

  • Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research

    SUSPENDED

    New York, New York, 10035, United States

  • Masina Hospital Trust

    RECRUITING

    Mumbai, Maharashtra, 400027, India

  • New Manak Healthcare Hospital

    RECRUITING

    Navi Mumbai, Maharashtra, 400706, India

  • Sentosa Hospital

    RECRUITING

    Kuching, 93250, Malaysia

  • Seth Sukhlal Karnani Memorial Hospital

    NOT_YET_RECRUITING

    Kolkata, West Bengal, 700025, India

  • Sultan Abdul Halim Hospital

    RECRUITING

    Sungai Petani, 08000, Malaysia

  • UCLA DGSOM, UCLA Health, UCLA Semel Institute

    SUSPENDED

    Los Angeles, California, 90095, United States

  • Udyan Health Care

    RECRUITING

    Lucknow, Uttar Pradesh, 226012, India

  • University of Miami, Miller School of Medicine; Jackson Behavioral Health Hospital

    SUSPENDED

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.